New drug development is at the core competency of Venturepharm labs. Venturepharm commits itself in new drug research and development to create best drugs or therapeutics for the health of the world.  As a result, a portfolio of over 400 products has been established, followed by many other novel products at  various pre-marketing stages of new drug development.

Venturepharm targets at the global pharmaceutical market in API (Active Pharmaceutical Ingredient), formulation development, clinical trial and product registration. The company has efficiently established networks of clients that cover North America, Europe, Africa and Asia. Leveraging on its vast capacity with integrated technology platforms, Venturepharm provides a "one-stop" service platform for comprehensive needs in new drug development.